July 28, 2016 10:43 AM EDT
R&D

Eli Lil­ly’s new CEO is ready to start part­ner­ing on R&D

John Carroll

Editor & Founder

Dur­ing John Lech­leit­er’s rule as CEO of Eli Lil­ly, the com­pa­ny’s em­pha­sis was al­ways on its own in­ter­nal pipeline. Lil­ly did a few pacts, al­most …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

A service from the Financial Times